Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KLEM study of perinatal lidocaine transmission
NL-OMON40012Active, not recruiting
- Sponsor
- Amphia Ziekenhuis
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lidocaine, sponsored by Amphia Ziekenhuis. Primary endpoints: Neonatal plasma lidocaine concentration at delivery and Maternal plasma lidocaine concentration at delivery. Started Jan 2013; status: active, not recruiting.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NL-OMON40012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40012.